Mette O. Pedersen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discordant cell-of-origin in refractory/relapsed LBCL at diagnosis and relapse.
Journal: Leukemia & lymphoma
Published: December 03, 2025
Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single-Center Cohort Study.
Journal: European journal of haematology
Published: June 21, 2025
Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation.
Journal: Annals of hematology
Published: November 12, 2024
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.
Journal: Leukemia & lymphoma
Published: February 10, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.
Journal: Med (New York, N.Y.)
Published: January 06, 2024
PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.
Journal: Hematological oncology
Published: May 08, 2019
Stratification by MYC expression has prognostic impact in MYC translocated B-cell lymphoma-Identifies a subgroup of patients with poor outcome.
Journal: European journal of haematology
Published: October 22, 2018
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Journal: PloS one
Published: May 11, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026